The TRIPLEX Study: Use of Patient-Derived Tumor Organoids as an Innovative Tool for Precision Medicine in Triple-Negative Breast Cancer

The TRIPLEX study was a single-center observational study conducted to investigate the feasibility of generating patient-derived tumor organoids from triple negative breast cancer and to evaluate their ability to predict clinical response.